Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$297K Sell
1,948
-1,148
-37% -$191K 0.02% 525
2026
Q1
$650K Sell
3,096
-515
-14% -$129K 0.06% 275
2025
Q4
$1.03M Sell
3,611
-267
-7% -$83.5K 0.1% 185
2025
Q3
$1.2M Sell
3,878
-654
-14% -$205K 0.12% 164
2025
Q2
$1.42M Sell
4,532
-268
-6% -$77.3K 0.15% 139
2025
Q1
$1.26M Sell
4,800
-1,362
-22% -$369K 0.15% 136
2024
Q4
$1.61M Buy
6,162
+561
+10% +$141K 0.18% 112
2024
Q3
$1.3M Buy
5,601
+2,123
+61% +$436K 0.15% 148
2024
Q2
$702K Buy
3,478
+760
+28% +$137K 0.14% 157
2024
Q1
$466K Buy
2,718
+934
+52% +$174K 0.09% 245
2023
Q4
$387K Buy
+1,784
New +$306K 0.07% 165

Other funds holding PODD

Norden Group's PODD Position: Q2 2026 in Review

Norden Group reduced its Insulet (PODD) stake by 37% in Q2 2026, selling an estimated $191K and leaving 1,948 shares worth $297K. The position accounts for 0.02% of the portfolio, ranked #525.

Norden Group first reported a position in PODD in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.61M in Q4 2024. 722 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Norden Group held 1,948 shares of Insulet worth $297K as of Q2 2026.
  • Norden Group sold 1,148 Insulet shares in Q2 2026, an estimated $191K.
  • Insulet made up 0.02% of Norden Group's portfolio in Q2 2026, its #525 holding.
  • Norden Group first reported a position in Insulet in Q4 2023 and has held it in 11 quarters since.
  • Norden Group's Insulet position peaked at $1.61M in Q4 2024.
  • 722 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.